Patent · US Active

Methods of 1H-indol-3-yl-2-oxoacetamide compounds

US7662834B2 · kind B2 · utility

0Cited by
9References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2008
Grant dateFeb 16, 2010
Priority date
Expiry dateJun 3, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to treating cancer or an angiogenesis-related disease using a compound of formula 1:wherein R1, R2, R3, R4, and n are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.